ATE302210T1 - Histogranin peptide und deren analgetische verwendung - Google Patents

Histogranin peptide und deren analgetische verwendung

Info

Publication number
ATE302210T1
ATE302210T1 AT98951127T AT98951127T ATE302210T1 AT E302210 T1 ATE302210 T1 AT E302210T1 AT 98951127 T AT98951127 T AT 98951127T AT 98951127 T AT98951127 T AT 98951127T AT E302210 T1 ATE302210 T1 AT E302210T1
Authority
AT
Austria
Prior art keywords
histogranin
peptides
compounds
analgesic use
compositions
Prior art date
Application number
AT98951127T
Other languages
English (en)
Inventor
Simon Lemaire
Original Assignee
Univ Ottawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2219437 external-priority patent/CA2219437A1/en
Application filed by Univ Ottawa filed Critical Univ Ottawa
Application granted granted Critical
Publication of ATE302210T1 publication Critical patent/ATE302210T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1019Tetrapeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/126Tetrapeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT98951127T 1997-10-24 1998-10-26 Histogranin peptide und deren analgetische verwendung ATE302210T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA 2219437 CA2219437A1 (en) 1997-10-24 1997-10-24 Peptides as analgesics
CA002224066A CA2224066A1 (en) 1997-10-24 1998-02-24 Peptides as analgesics
PCT/CA1998/001002 WO1999021877A1 (en) 1997-10-24 1998-10-26 Histogranin peptide and their analgesic use

Publications (1)

Publication Number Publication Date
ATE302210T1 true ATE302210T1 (de) 2005-09-15

Family

ID=25679768

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98951127T ATE302210T1 (de) 1997-10-24 1998-10-26 Histogranin peptide und deren analgetische verwendung

Country Status (7)

Country Link
US (2) US6566327B1 (de)
EP (1) EP1025119B1 (de)
AT (1) ATE302210T1 (de)
AU (1) AU9731198A (de)
CA (1) CA2224066A1 (de)
DE (1) DE69831257D1 (de)
WO (1) WO1999021877A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2224066A1 (en) * 1997-10-24 1999-04-24 Universite D'ottawa/ University Of Ottawa Peptides as analgesics
US6972281B2 (en) * 2002-02-07 2005-12-06 University Of Ottawa Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
US7842662B2 (en) 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
US7713937B2 (en) 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
US8236766B2 (en) 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
RU2500685C2 (ru) 2006-11-10 2013-12-10 Кара Терапеутикс, Инк Синтетические пептидные амиды
US8906859B2 (en) 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
US10815276B2 (en) 2014-05-21 2020-10-27 Entrada Therapeutics, Inc. Cell penetrating peptides and methods of making and using thereof
JP6807831B2 (ja) 2014-05-21 2021-01-06 エントラーダ セラピューティクス,インコーポレイテッド 細胞膜透過性ペプチド、並びにこの作製方法及び使用方法
WO2016033368A1 (en) 2014-08-27 2016-03-03 Ohio State Innovation Foundation Improved peptidyl calcineurin inhibitors
CA3078504A1 (en) 2017-10-04 2019-04-11 Ohio State Innovation Foundation Bicyclic peptidyl inhibitors
WO2019148195A2 (en) 2018-01-29 2019-08-01 Ohio State Innovation Foundation Cyclic peptidyl inhibitors of cal-pdz binding domain
WO2019148194A2 (en) 2018-01-29 2019-08-01 Ohio State Innovation Foundation Peptidyl inhibitors of calcineurin-nfat interaction
WO2019165183A1 (en) 2018-02-22 2019-08-29 Entrada Therapeutics, Inc. Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
US11987647B2 (en) 2018-05-09 2024-05-21 Ohio State Innovation Foundation Cyclic cell-penetrating peptides with one or more hydrophobic residues

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416871A (en) 1978-07-10 1983-11-22 The United States Of America As Represented By The Department Of Health And Human Services Inhibition by peptides of tolerance to and physical dependence on morphine
US4631270A (en) 1978-11-20 1986-12-23 Research Corporation Therapeutically useful pseudopeptides, compositions containing the same and methods of preparation and use
US5807828A (en) 1989-06-16 1998-09-15 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5216124A (en) 1989-12-15 1993-06-01 G. D. Searle & Co. Substituted cyclic tetrapeptides
US5169833A (en) 1989-12-15 1992-12-08 G. D. Searle & Co. Substituted cyclic pentapeptides
DK53291D0 (da) * 1991-03-25 1991-03-25 Carlbiotech Ltd As Smaa peptider og peptidrelaterede stoffer samt farmaceutiske praeparater indeholdende saadanne forbindelser
US5656267A (en) 1991-08-22 1997-08-12 Sagen; Jacqueline Implantable cells that alleviate chronic pain in humans
WO1993013128A1 (en) 1991-12-30 1993-07-08 Neurex Corporation Methods of producing analgesia and enhancing opiate analgesia
CA2097533A1 (en) 1992-06-03 1993-12-04 Simon Lemaire Peptides having neuroprotective and immunostimulatory functions
US5470753A (en) * 1992-09-03 1995-11-28 Selectide Corporation Peptide sequencing using mass spectrometry
AUPM473294A0 (en) 1994-03-25 1994-04-21 Franklyn, Kathleen Mary Peptides for diagnostics and therapeutics
US5811391A (en) 1994-08-25 1998-09-22 Cytel Corporation Cyclic CS-1 peptidomimetics, compositions and methods of using same
WO1996006626A1 (en) 1994-08-26 1996-03-07 Lee Nancy M Analgesic method with dynorphin analogues truncated at the n-terminus
US5817750A (en) 1995-08-28 1998-10-06 La Jolla Cancer Research Foundation Structural mimics of RGD-binding sites
CA2224066A1 (en) * 1997-10-24 1999-04-24 Universite D'ottawa/ University Of Ottawa Peptides as analgesics

Also Published As

Publication number Publication date
US6855692B2 (en) 2005-02-15
US6566327B1 (en) 2003-05-20
CA2224066A1 (en) 1999-04-24
EP1025119A1 (de) 2000-08-09
EP1025119B1 (de) 2005-08-17
AU9731198A (en) 1999-05-17
WO1999021877A1 (en) 1999-05-06
US20040006013A1 (en) 2004-01-08
DE69831257D1 (de) 2005-09-22

Similar Documents

Publication Publication Date Title
ATE302210T1 (de) Histogranin peptide und deren analgetische verwendung
ATE249422T1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
BR9607260A (pt) Utilização de aerogéis em agricultura
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
EP1015008A4 (de) Verbindungen und zusammensetzungen zur administration aktiver stoffe
ATE280826T1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
DK0728148T3 (da) Forbedrede immunogene sammensætninger mod humant gastrin 17
ATE389724T1 (de) Menschliche dnase i hyperaktive varianten
ATE393831T1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
PT957940E (pt) Composicoes farmaceuticas contendo "gellants" na forma de alquil amidas de acidos di- e tri-carboxilicos
DE69905170D1 (en) Thiazolopyrimidinderivate
ZA98214B (en) Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1.
DE69531098D1 (de) Piperidine und pyrrolidine
ATE280777T1 (de) Bradykinin-antagonist peptide mit n- substituierten glycinen
YU13301A (sh) Muskarinski agonisti i antagonisti
AR003589A1 (es) Utilizacion de una cantidad eficaz de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento destinada paratratar la inflamacion, y un procedimiento de tratamiento cosmetico mediante una composicion cosmetica que contiene a dicho peptido.
DE60118956D1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
DE69907926D1 (de) 1,2,4-triazol-3-thion verbindungen
BR0312889A (pt) Polipeptìdeo t20 peguilado
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
GB2331926A (en) Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine
SG142165A1 (en) Biologically active peptides
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
DE59811656D1 (en) Kombinationspräparat aus 2-methylthiazolidin-2,4-dicarbonsäure und paracetamol
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties